ArticleFrontiers in oncology2022

Pseudoprogression after advanced first-line endocrine therapy in metastatic breast cancer with bone metastasis: A case report.

Aijuan Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.